100 related articles for article (PubMed ID: 16223531)
1. Characterization of relapsing autoimmune encephalomyelitis and its treatment with decoy chemokine receptor genes.
Matsumo Y; Sakuma H; Miyakoshi A; Tsukada Y; Kohyama K; Park IK; Tanuma N
J Neuroimmunol; 2005 Dec; 170(1-2):49-61. PubMed ID: 16223531
[TBL] [Abstract][Full Text] [Related]
2. Characterization of CD8-positive macrophages infiltrating the central nervous system of rats with chronic autoimmune encephalomyelitis.
Hiraki K; Park IK; Kohyama K; Matsumoto Y
J Neurosci Res; 2009 Apr; 87(5):1175-84. PubMed ID: 18951531
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: implication for pathomechanisms of lesion formation.
Park IK; Hiraki K; Kohyama K; Matsumoto Y
J Neuroimmunol; 2008 Feb; 194(1-2):34-43. PubMed ID: 18155779
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
[TBL] [Abstract][Full Text] [Related]
5. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
6. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
7. In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis.
Chen W; Li H; Jia Y; Lv M; Li M; Feng P; Hu H; Zhang L
J Autoimmun; 2007 Feb; 28(1):30-40. PubMed ID: 17267177
[TBL] [Abstract][Full Text] [Related]
8. Preferential distribution of V beta 8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis.
Tsuchida M; Matsumoto Y; Hirahara H; Hanawa H; Tomiyama K; Abo T
Eur J Immunol; 1993 Oct; 23(10):2399-406. PubMed ID: 7691605
[TBL] [Abstract][Full Text] [Related]
9. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
[TBL] [Abstract][Full Text] [Related]
11. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
[TBL] [Abstract][Full Text] [Related]
12. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
Chen GQ; Chen YY; Wang XS; Wu SZ; Yang HM; Xu HQ; He JC; Wang XT; Chen JF; Zheng RY
Brain Res; 2010 Jan; 1309():116-25. PubMed ID: 19879252
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats.
Sakuma H; Kohyama K; Park IK; Miyakoshi A; Tanuma N; Matsumoto Y
Brain; 2004 Oct; 127(Pt 10):2201-13. PubMed ID: 15282218
[TBL] [Abstract][Full Text] [Related]
14. Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis.
Nguyen KB; McCombe PA; Pender MP
J Autoimmun; 1994 Apr; 7(2):145-52. PubMed ID: 8037835
[TBL] [Abstract][Full Text] [Related]
15. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
Matejuk A; Adlard K; Zamora A; Silverman M; Vandenbark AA; Offner H
J Neurosci Res; 2001 Sep; 65(6):529-42. PubMed ID: 11550221
[TBL] [Abstract][Full Text] [Related]
16. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
17. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
[TBL] [Abstract][Full Text] [Related]
18. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis.
Narumi S; Kaburaki T; Yoneyama H; Iwamura H; Kobayashi Y; Matsushima K
Eur J Immunol; 2002 Jun; 32(6):1784-91. PubMed ID: 12115662
[TBL] [Abstract][Full Text] [Related]
20. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
